Understanding post-COVID-19 illegal wildlife-based medicine consumption to inform effective interventions
Key Facts
FUNDING SCHEME Covid19 Rapid Response
VALUE £30,859
WHERE China
Summary
This project will compare unique pre-COVID-19 baseline data to post-COVID-19 surveys and interviews with the public, consumers, and medical practitioners, to look at how bear bile consumption has changed in China during the pandemic. It will also collect data on pandemic-related consumption of key illegal wildlife-based medicines (e.g. tiger bone). This will identify high-risk consumer groups, who will participate in co-design workshops, developing prototype interventions to reduce illegal wildlife consumption in post-COVID-19 China, and in other countries with similar markets.
